Neutrophil depletion attenuates placental ischemia-induced hypertension in the rat

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Regal, Jean F ^a   Lillegard, Kathryn E ^a,b   Bauer, Ashley J ^a,c   Elmquist, Barbara J ^a   Loeks Johnson, Alex C ^a   Gilbert, Jeffrey S ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Data Sciences International   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE ANTIBODY; ANTISERUM; COMPLEMENT COMPONENT C3A; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETER; ARTICLE; CONTROLLED STUDY; FEMALE; ISCHEMIA; MATERNAL HYPERTENSION; MEAN ARTERIAL PRESSURE; MOUSE; NEUTROPHIL; NONHUMAN; PERFUSION PRESSURE; PLACENTAL ISCHEMIA; PREECLAMPSIA; REDUCED UTEROPLACENTAL PERFUSION PRESSURE; ANIMAL; BLOOD; COMPLICATION; DISEASE MODEL; HYPERTENSION, PREGNANCY-INDUCED; IMMUNOLOGY; INNATE IMMUNITY; LEUKAPHERESIS; LEUKOCYTE COUNT; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA; PLACENTA CIRCULATION; PRE-ECLAMPSIA; PREGNANCY; RAT; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ORYCTOLAGUS CUNICULUS; RATTUS;

ANIMALS; COMPLEMENT C3A; DISEASE MODELS, ANIMAL; FEMALE; HYPERTENSION, PREGNANCY-INDUCED; IMMUNE SERA; IMMUNITY, INNATE; ISCHEMIA; LEUKOCYTE COUNT; LEUKOCYTE REDUCTION PROCEDURES; NEUTROPHILS; OXIDATIVE STRESS; PLACENTA; PLACENTAL CIRCULATION; PRE-ECLAMPSIA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84940056527     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132063     Document Type: Article

References (71)

1. Lo JO, Mission JF, Caughey AB. Hypertensive disease of pregnancy and maternal mortality. Current opinion in obstetrics & gynecology. 2013; 25(2):124-32. Epub 2013/02/14. doi: 10.1097/GCO. 0b013e32835e0ef5 PMID: 23403779.
2. LaMarca B, Cornelius D, Wallace K. Elucidating immune mechanisms causing hypertension during pregnancy. Physiology (Bethesda). 2013; 28(4):225-33. Epub 2013/07/03. doi: 10.1152/physiol. 00006.2013 PMID: 23817797; PubMed Central PMCID: PMC3742131.
3. Palei AC, Spradley FT, Warrington JP, George EM, Granger JP. Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology. Acta Physiol (Oxf). 2013; 208(3):224-33. Epub 2013/ 04/18. doi: 10.1111/apha.12106 PMID: 23590594; PubMed Central PMCID: PMC3687012.
4. Snydal S. Major changes in diagnosis and management of preeclampsia. Journal of midwifery & women's health. 2014; 59(6):596-605. Epub 2014/11/08. doi: 10.1111/jmwh.12260 PMID: 25377651.
5. Maynard S, Epstein FH, Karumanchi SA. Preeclampsia and angiogenic imbalance. Annual review of medicine. 2008; 59:61-78. Epub 2007/10/17. doi: 10.1146/annurev.med.59.110106.214058 PMID: 17937587.
6. Alijotas-Reig J, Llurba E, Gris JM. Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells. Placenta. 2014; 35(4):241-8. Epub 2014/03/04. doi: 10.1016/j. placenta.2014.02.004 PMID: 24581729.
7. Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol. 2010; 63(6):601-10. Epub 2010/05/12. doi: 10.1111/j.1600-0897.2010.00852.x PMID: 20455873.
8. Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia. J Leukoc Biol. 2013; 94(2):247-57. Epub 2013/05/02. doi: 10.1189/jlb.1112603 PMID: 23633414.
9. Derzsy Z, Prohaszka Z, Rigo J Jr., Fust G, Molvarec A. Activation of the complement system in normal pregnancy and preeclampsia. Mol Immunol. 2010; 47(7-8):1500-6. Epub 2010/02/26. S0161-5890 (10)00033-7 [pii] doi: 10.1016/j.molimm.2010.01.021 PMID: 20181396.
10. Denny KJ, Woodruff TM, Taylor SM, Callaway LK. Complement in pregnancy: a delicate balance. Am J Reprod Immunol. 2013; 69(1):3-11. Epub 2012/08/29. PMID: 22925193. doi: 10.1111/aji.12000
11. Pitkin RM, Witte DL. Platelet and leukocyte counts in pregnancy. JAMA. 1979; 242(24):2696-8. Epub 1979/12/14. PMID: 501868.
12. Lurie S, Frenkel E, Tuvbin Y. Comparison of the differential distribution of leukocytes in preeclampsia versus uncomplicated pregnancy. Gynecologic and obstetric investigation. 1998; 45(4):229-31. Epub 1998/06/12. PMID: 9623786.
13. Gupta AK, Gebhardt S, Hillermann R, Holzgreve W, Hahn S. Analysis of plasma elastase levels in early and late onset preeclampsia. Archives of gynecology and obstetrics. 2006; 273(4):239-42. Epub 2005/ 11/18. doi: 10.1007/s00404-005-0093-z PMID: 16292578.
14. Butterworth BH, Greer IA, Liston WA, Haddad NG, Johnston TA. Immunocytochemical localization of neutrophil elastase in term placenta decidua and myometrium in pregnancy-induced hypertension. British journal of obstetrics and gynaecology. 1991; 98(9):929-33. Epub 1991/09/01. PMID: 1911612.
15. Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998; 179(1):80-6. Epub 1998/08/15. PMID: 9704769.
16. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999; 180(2 Pt 1):499-506. Epub 1999/02/13. PMID: 9988826.
17. Clark P, Boswell F, Greer IA. The neutrophil and preeclampsia. Seminars in reproductive endocrinology. 1998; 16(1):57-64. Epub 1998/07/09. doi: 10.1055/s-2007-1016253 PMID: 9654608.
18. Greer IA, Dawes J, Johnston TA, Calder AA. Neutrophil activation is confined to the maternal circulation in pregnancy-induced hypertension. Obstet Gynecol. 1991; 78(1):28-32. Epub 1991/07/01. PMID: 2047063.
19. Safronova VG, Matveeva NK, Avkhacheva NV, Sidel'nikova VM, Van'ko LV, Sukhikh GT. Changes in regulation of oxidase activity of peripheral blood granulocytes in women with habitual abortions. Bull Exp Biol Med. 2003; 136(3):257-60. Epub 2003/12/11. PMID: 14666189.
20. Hempstock J, Jauniaux E, Greenwold N, Burton GJ. The contribution of placental oxidative stress to early pregnancy failure. Human pathology. 2003; 34(12):1265-75. Epub 2003/12/24. PMID: 14691912.
21. Jauniaux E, Hempstock J, Greenwold N, Burton GJ. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol. 2003; 162(1):115-25. Epub 2003/01/01. doi: 10.1016/S0002-9440(10)63803-5 PMID: 12507895; PubMed Central PMCID: PMC1851128.
22. Redecha P, Tilley R, Tencati M, Salmon JE, Kirchhofer D, Mackman N, et al. Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood. 2007; 110(7):2423-31. Epub 2007/05/31. doi: 10.1182/blood-2007-01-070631 PMID: 17536017; PubMed Central PMCID: PMC1988945.
23. Cadden KA, Walsh SW. Neutrophils, but not lymphocytes or monocytes, infiltrate maternal systemic vasculature in women with preeclampsia. Hypertension in pregnancy: official journal of the International Society for the Study of Hypertension in Pregnancy. 2008; 27(4):396-405. Epub 2008/11/13. doi: 10. 1080/10641950801958067 PMID: 19003640; PubMed Central PMCID: PMC2593156.
24. Shukla J, Walsh SW. Neutrophil Release of Myeloperoxidase in Systemic Vasculature of Obese Women May Put Them at Risk for Preeclampsia. Reprod Sci. 2014. Epub 2014/11/15. 10.1177/ 1933719114557899. 25394640.
25. Clark DA, Chaouat G, Arck PC, Mittruecker HW, Levy GA. Cytokine-dependent abortion in CBA x DBA/ 2 mice is mediated by the procoagulant fgl2 prothrombinase [correction of prothombinase]. J Immunol. 1998; 160(2):545-9. Epub 1998/04/29. PMID: 9551885.
26. Girardi G, Berman J, Redecha P, Spruce L, Thurman JM, Kraus D, et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest. 2003; 112 (11):1644-54. Epub 2003/12/09. doi: 10.1172/JCI18817 112/11/1644 [pii] PMID: 14660741; PubMed Central PMCID: PMC281643.
27. Rinaldi SF, Catalano RD, Wade J, Rossi AG, Norman JE. Decidual neutrophil infiltration is not required for preterm birth in a mouse model of infection-induced preterm labor. J Immunol. 2014; 192(5):2315- 25. Epub 2014/02/07. doi: 10.4049/jimmunol.1302891 PMID: 24501200; PubMed Central PMCID: PMC3932811.
28. Kirabo A, Fontana V, de Faria AP, Loperena R, Galindo CL, Wu J, et al. DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Invest. 2014; 124(10):4642-56. Epub 2014/09/23. doi: 10.1172/JCI74084 PMID: 25244096; PubMed Central PMCID: PMC4220659.
29. Mattson DL. Infiltrating immune cells in the kidney in salt-sensitive hypertension and renal injury. American journal of physiology Renal physiology. 2014; 307(5):F499-508. Epub 2014/07/11. doi: 10.1152/ ajprenal.00258.2014 PMID: 25007871; PubMed Central PMCID: PMC4154114.
30. Mazor R, Kristal B, Cohen-Mazor M, Yagil C, Yagil Y, Sela S. The polymorphonuclear leukocyte contributes to the development of hypertension in the Sabra rat. J Hypertens. 2007; 25(11):2249-56. Epub 2007/10/09. doi: 10.1097/HJH.0b013e3282dd79b6 PMID: 17921819.
31. Lillegard KE, Johnson AC, Lojovich SJ, Bauer AJ, Marsh HC, Gilbert JS, et al. Complement activation is critical for placental ischemia-induced hypertension in the rat. Mol Immunol. 2013; 56(1-2):91-7. Epub 2013/05/21. doi: 10.1016/j.molimm.2013.04.009 PMID: 23685261; PubMed Central PMCID: PMC3687024.
32. Lillegard KE, Loeks-Johnson AC, Opacich JW, Peterson JM, Bauer AJ, Elmquist BJ, et al. Differential effects of complement activation products c3a and c5a on cardiovascular function in hypertensive pregnant rats. J Pharmacol Exp Ther. 2014; 351(2):344-51. Epub 2014/08/26. doi: 10.1124/jpet.114. 218123 PMID: 25150279.
33. Gilbert JS, Verzwyvelt J, Colson D, Arany M, Karumanchi SA, Granger JP. Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension. Hypertension. 2010; 55(2):380-5. Epub 2009/12/23. doi: 10. 1161/HYPERTENSIONAHA.109.141937 PMID: 20026764; PubMed Central PMCID: PMC2824248.
34. Alexander BT, Kassab SE, Miller MT, Abram SR, Reckelhoff JF, Bennett WA, et al. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension. 2001; 37(4):1191-5. Epub 2001/04/17. PMID: 11304523.
35. Gandley RE, Rohland J, Zhou Y, Shibata E, Harger GF, Rajakumar A, et al. Increased myeloperoxidase in the placenta and circulation of women with preeclampsia. Hypertension. 2008; 52(2):387-93. Epub 2008/07/02. doi: 10.1161/HYPERTENSIONAHA.107.107532 PMID: 18591459; PubMed Central PMCID: PMC2735015.
36. Searle J, Mockel M, Gwosc S, Datwyler SA, Qadri F, Albert GI, et al. Heparin strongly induces soluble fms-like tyrosine kinase 1 release in vivo and in vitro-brief report. Arteriosclerosis, thrombosis, and vascular biology. 2011; 31(12):2972-4. Epub 2011/10/08. doi: 10.1161/ATVBAHA.111.237784 PMID: 21979436.
37. Gilbert J, Dukes M, LaMarca B, Cockrell K, Babcock S, Granger J. Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats. Am J Hypertens. 2007; 20(6):686- 91. Epub 2007/05/29. doi: 10.1016/j.amjhyper.2006.12.016 PMID: 17531929.
38. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension. 2007; 50 (6):1142-7. Epub 2007/10/10. HYPERTENSIONAHA.107.096594 [pii] doi: 10.1161/ HYPERTENSIONAHA.107.096594 PMID: 17923588.
39. Fraser DG, Regal JF, Arndt ML. Trimellitic anhydride-induced allergic response in the lung: role of the complement system in cellular changes. J Pharmacol Exp Ther. 1995; 273(2):793-801. PMID: 7752082.
40. Regal JF, Klos A. Minor role of the C3a receptor in systemic anaphylaxis in the guinea pig. Immunopharmacology. 2000; 46(1):15-28. PMID: 10665776.
41. Bauer AJ, Banek CT, Needham K, Gillham H, Capoccia S, Regal JF, et al. Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension. Hypertension. 2013; 61(5):1103-10. Epub 2013/03/06. doi: 10.1161/ HYPERTENSIONAHA.111.00226 PMID: 23460290.
42. Weissgerber TL, McConico A, Knudsen BE, Butters KA, Hayman SR, White WM, et al. Methodological differences account for inconsistencies in reported free VEGF concentrations in pregnant rats. Am J Physiol Regul Integr Comp Physiol. 2014; 306(11):R796-803. Epub 2014/03/14. doi: 10.1152/ajpregu. 00544.2013 PMID: 24622973; PubMed Central PMCID: PMC4042202.
43. Leik CE, Walsh SW. Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia. Hypertension. 2004; 44(1):72-7. Epub 2004/05/19. doi: 10.1161/01.HYP.0000130483. 83154.37 PMID: 15148293.
44. LaMarca B, Wallace K, Herse F, Wallukat G, Martin JN Jr., Weimer A, et al. Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes. Hypertension. 2011; 57(4):865-71. Epub 2011/03/02. doi: 10.1161/HYPERTENSIONAHA.110.167569 PMID: 21357287; PubMed Central PMCID: PMC3109629.
45. Novotny SR, Wallace K, Heath J, Moseley J, Dhillon P, Weimer A, et al. Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats. Am J Physiol Regul Integr Comp Physiol. 2012; 302(10):R1197-201. Epub 2012/03/31. doi: 10.1152/ajpregu.00623.2011 PMID: 22461177; PubMed Central PMCID: PMC3362148.
46. Wallace K, Cornelius DC, Scott J, Heath J, Moseley J, Chatman K, et al. CD4+ T Cells Are Important Mediators of Oxidative Stress That Cause Hypertension in Response to Placental Ischemia. Hypertension. 2014; 64(5):1151-8. Epub 2014/09/27. doi: 10.1161/HYPERTENSIONAHA.114.03590 PMID: 25259742.
47. Jaremo P, Lindahl TL, Lennmarken C, Forsgren H. The use of platelet density and volume measurements to estimate the severity of pre-eclampsia. European journal of clinical investigation. 2000; 30 (12):1113-8. Epub 2000/12/21. PMID: 11122327.
48. Gupta AK, Hasler P, Holzgreve W, Gebhardt S, Hahn S. Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. Human immunology. 2005; 66(11):1146-54. Epub 2006/03/31. doi: 10.1016/j.humimm.2005.11.003 PMID: 16571415.
49. Ssemaganda A, Kindinger L, Bergin P, Nielsen L, Mpendo J, Ssetaala A, et al. Characterization of neutrophil subsets in healthy human pregnancies. PloS one. 2014; 9(2):e85696. Epub 2014/02/20. doi: 10. 1371/journal.pone.0085696 PMID: 24551035; PubMed Central PMCID: PMC3923728.
50. Sedeek M, Gilbert JS, LaMarca BB, Sholook M, Chandler DL, Wang Y, et al. Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats. Am J Hypertens. 2008; 21(10):1152-6. Epub 2008/08/02. doi: 10.1038/ajh.2008.239 PMID: 18670418; PubMed Central PMCID: PMC2786058.
51. Llurba E, Gratacos E, Martin-Gallan P, Cabero L, Dominguez C. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free radical biology & medicine. 2004; 37(4):557-70. Epub 2004/07/17. doi: 10.1016/j.freeradbiomed.2004.04.035 PMID: 15256227.
52. Cornelius DC, Hogg JP, Scott J, Wallace K, Herse F, Moseley J, et al. Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy. Hypertension. 2013; 62(6):1068-73. Epub 2013/09/26. doi: 10.1161/ HYPERTENSIONAHA.113.01514 PMID: 24060899; PubMed Central PMCID: PMC3899693.
53. Banek CT, Bauer AJ, Needham KM, Dreyer HC, Gilbert JS. AICAR administration ameliorates hypertension and angiogenic imbalance in a model of preeclampsia in the rat. Am J Physiol Heart Circ Physiol. 2013; 304(8):H1159-65. Epub 2013/02/19. doi: 10.1152/ajpheart.00903.2012 PMID: 23417865; PubMed Central PMCID: PMC3625906.
54. Hartney JM, Stidham T, Goldstrohm DA, Oberley-Deegan RE, Weaver MR, Valnickova-Hansen Z, et al. A common polymorphism in extracellular superoxide dismutase affects cardiopulmonary disease risk by altering protein distribution. Circulation Cardiovascular genetics. 2014; 7(5):659-66. Epub 2014/ 08/03. doi: 10.1161/CIRCGENETICS.113.000504 PMID: 25085920; PubMed Central PMCID: PMC4270938.
55. Buhimschi IA, Shi SQ, Saade GR, Garfield RE. Marked variation in responses to long-term nitric oxide inhibition during pregnancy in outbred rats from two different colonies. Am J Obstet Gynecol. 2001; 184 (4):686-93. Epub 2001/03/23. doi: 10.1067/mob.2001.110448 PMID: 11262473.
56. Griffin K, Polichnowski A, Licea-Vargas H, Picken M, Long J, Williamson G, et al. Large BP-dependent and-independent differences in susceptibility to nephropathy after nitric oxide inhibition in Sprague- Dawley rats from two major suppliers. American journal of physiology Renal physiology. 2012; 302(1): F173-82. Epub 2011/09/23. doi: 10.1152/ajprenal.00070.2011 PMID: 21937607; PubMed Central PMCID: PMC3251341.
57. Pollock DM, Rekito A. Hypertensive response to chronic NO synthase inhibition is different in Sprague- Dawley rats from two suppliers. The American journal of physiology. 1998; 275(5 Pt 2):R1719-23. Epub 1998/10/29. PMID: 9791095.
58. Proctor LM, Arumugam TV, Shiels I, Reid RC, Fairlie DP, Taylor SM. Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury. Br J Pharmacol. 2004; 142(4):756-64. Epub 2004/05/26. doi: 10.1038/sj.bjp.0705819 PMID: 15159277; PubMed Central PMCID: PMC1575041.
59. Proctor LM, Moore TA, Monk PN, Sanderson SD, Taylor SM, Woodruff TM. Complement factors C3a and C5a have distinct hemodynamic effects in the rat. International immunopharmacology. 2009; 9 (6):800-6. Epub 2009/03/17. doi: 10.1016/j.intimp.2009.03.002 PMID: 19285573.
60. Coulthard LG, Woodruff TM. Is the Complement Activation Product C3a a Proinflammatory Molecule? Re-evaluating the Evidence and the Myth. J Immunol. 2015; 194(8):3542-8. Epub 2015/04/08. doi: 10. 4049/jimmunol.1403068 PMID: 25848071.
61. Wu MC, Brennan FH, Lynch JP, Mantovani S, Phipps S, Wetsel RA, et al. The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization. Proc Natl Acad Sci U S A. 2013; 110(23):9439-44. Epub 2013/05/23. doi: 10.1073/ pnas.1218815110 PMID: 23696668; PubMed Central PMCID: PMC3677481.
62. Elferink JG, de Koster BM. Endothelin-induced activation of neutrophil migration. Biochem Pharmacol. 1994; 48(5):865-71. Epub 1994/08/30. PMID: 8093098.
63. Alexander BT, Rinewalt AN, Cockrell KL, Massey MB, Bennett WA, Granger JP. Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension. 2001; 37(2 Part 2):485-9. Epub 2001/03/07. PMID: 11230323.
64. Wang W, Irani RA, Zhang Y, Ramin SM, Blackwell SC, Tao L, et al. Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia. Hypertension. 2012; 60 (3):712-21. Epub 2012/08/08. doi: 10.1161/HYPERTENSIONAHA.112.191817 PMID: 22868393.
65. George EM, Hosick PA, Stec DE, Granger JP. Heme oxygenase inhibition increases blood pressure in pregnant rats. Am J Hypertens. 2013; 26(7):924-30. Epub 2013/04/05. doi: 10.1093/ajh/hpt045 PMID: 23553216; PubMed Central PMCID: PMC3731822.
66. Vonnahme KA, Wilson ME, Li Y, Rupnow HL, Phernetton TM, Ford SP, et al. Circulating levels of nitric oxide and vascular endothelial growth factor throughout ovine pregnancy. J Physiol. 2005; 565(Pt 1):101-9. Epub 2005/03/19. doi: 10.1113/jphysiol.2004.082321 PMID: 15774525; PubMed Central PMCID: PMC1464494.
67. Gladigau G, Haselmayer P, Scharrer I, Munder M, Prinz N, Lackner K, et al. A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome. PloS one. 2012; 7(7):e42176. Epub 2012/08/04. doi: 10.1371/journal.pone.0042176 PMID: 22860075; PubMed Central PMCID: PMC3409186.
68. Kim J, Yun H, Lim K, Suh J, Chung M. Haematological values during normal pregnancy in Sprague- Dawley rats. Comparative Haematology International. 2000; 10:74-9. Epub 2000.
69. LaMarca B, Speed J, Fournier L, Babcock SA, Berry H, Cockrell K, et al. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension. 2008; 52(6):1161-7. Epub 2008/11/05. doi: 10.1161/HYPERTENSIONAHA.108.120881 PMID: 18981324; PubMed Central PMCID: PMC2788766.
70. Murphy SR, LaMarca BB, Parrish M, Cockrell K, Granger JP. Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-alpha. Am J Physiol Regul Integr Comp Physiol. 2013; 304(2):R130-5. Epub 2012/11/30. doi: 10.1152/ajpregu. 00069.2012 PMID: 23193111; PubMed Central PMCID: PMC3543655.
71. LaMarca B, Wallukat G, Llinas M, Herse F, Dechend R, Granger JP. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension. 2008; 52(6):1168-72. Epub 2008/10/15. doi: 10.1161/HYPERTENSIONAHA.108. 120576 PMID: 18852381; PubMed Central PMCID: PMC2782765.